Viking Therapeutics, Inc.VKTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank92
3Y CAGR+182.9%
5Y CAGR+60.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+182.9%/yr
vs -22.4%/yr prior
5Y CAGR
+60.5%/yr
Recent acceleration
Acceleration
+205.3pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
10.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $33.70M | -17.7% |
| 2024 | $40.96M | +174.3% |
| 2023 | $14.93M | +903.5% |
| 2022 | $1.49M | +115.0% |
| 2021 | $692000.00 | -78.1% |
| 2020 | $3.17M | -54.2% |
| 2019 | $6.91M | +68.6% |
| 2018 | $4.10M | +371.8% |
| 2017 | $-1.51M | -70.4% |
| 2016 | $-884547.00 | - |